iPSYDE: Internet-based Psychotherapy for Depressed Elderly

Sponsor
Vilnius University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04728204
Collaborator
Linkoeping University (Other)
80
1
2
28.1
2.9

Study Details

Study Description

Brief Summary

This study aims to evaluate the effectiveness of internet-based cognitive behavioral therapy (CBT) for depressed elderly.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Depresijos terapija
N/A

Detailed Description

Individuals of age 60+ with symptoms of depression will be assessed before the study. At week 0, participants who meet eligibility requirements will be randomized either to intervention group which will participate in an 8-week internet-based modular CBT or to a delayed treatment control group.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be randomized to either control or intervention group. Participants in the control group will receive the same treatment after the intervention group is finished with the treatment.Participants will be randomized to either control or intervention group. Participants in the control group will receive the same treatment after the intervention group is finished with the treatment.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Internet-based Cognitive Behavioral Therapy for Depressed Elderly: a Two-armed Randomized Controlled Trial
Actual Study Start Date :
Jan 28, 2021
Anticipated Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

8 module, 8 week long internet-based intervention for reducing burden of depression

Behavioral: Depresijos terapija
Intervention is based on the principles of cognitive behavioral therapy and culturally adapted to elderly Lithuanian population. The main purpose of the intervention is to reduce the symptoms of depression and increase psychological well-being. Intervention contains psychoeducation, examples, exercises and consultation with a psychologist.

No Intervention: Control group

Participants randomized to the control group will be instructed to wait until the intervention group finishes the treatment and that they will be able to use the same intervention afterwards.

Outcome Measures

Primary Outcome Measures

  1. Patient Health Questionnaire (PHQ-9) [Pre-treatment, week 8, 3, 12 and 24 months post-treatment]

    Change from baseline in depression symptoms post-treatment (week 8), at three months, at 12 months and at 24 months post-treatment. Measure contains 9 questions that have to be responded to by choosing an answer from a 4-item Likert scale, where number 0 indicates 'Not at all' and 3 - 'Nearly every day'. Higher score indicates more severe symptoms.

  2. Geriatric Depression Scale (GDS) [Pre-treatment, week 8, 3, 12 and 24 months post-treatment]

    Change from baseline in depression symptoms post-treatment (week 8), at three months, at 12 months and at 24 months post-treatment. Measure contains 15 questions that have to be responded 'Yes' or 'No'. Higher score indicates more severe symptoms.

Secondary Outcome Measures

  1. Generalized Anxiety Disorder-7 (GAD-7) [Pre-treatment, week 8, 3, 12 and 24 months post-treatment]

    Change from baseline in anxiety symptoms post-treatment (week 8), at three months, at 12 months and at 24 months post-treatment. Measure contains 7 questions that have to be responded to by choosing an answer from a 4-item Likert scale, where number 0 indicates 'Not at all' and 3 - 'Nearly every day'. Higher score indicates more severe symptoms.

  2. The World Health Organisation- Five Well-Being Index (WHO-5) [Pre-treatment, week 8, 3, 12 and 24 months post-treatment]

    Change from baseline in well-being post-treatment (week 8), at three months, at 12 months and at 24 months post-treatment. WHO-5 contains 5 statements about individuals well-being in the past two weeks. Respondents have to choose the best corresponding answer using a 6-item Likert scale where a score of 0 indicates 'At no time' and a score of 5 - 'All the time'. Higher score indicates higher well-being.

Other Outcome Measures

  1. The Alcohol Use Disorders Identification Test (AUDIT) [Pre-treatment]

    AUDIT will be used for alcohol consumption and related risks assessment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • depressive symptoms

  • have access to a computer/tablet/smartphone and to the internet

  • have good knowledge of the Lithuanian language

Exclusion Criteria:
  • alcohol addiction

  • presently in any other psychological treatment

  • severe depression

  • suicidal ideation

  • significant change in psychiatric medication (during last 6 weeks)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vilnius University Vilnius Lithuania LT-01513

Sponsors and Collaborators

  • Vilnius University
  • Linkoeping University

Investigators

  • Principal Investigator: Jonas Eimontas, PhD, Vilnius University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vilnius University
ClinicalTrials.gov Identifier:
NCT04728204
Other Study ID Numbers:
  • iPSYDE_1_2021
First Posted:
Jan 28, 2021
Last Update Posted:
Apr 23, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Vilnius University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 23, 2021